Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Patent reform and intellectual property issues, including issues surrounding patent settlements HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding follow-on biologics/pathway for biosimilar pharmaceuticals
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · first_quarter · Q1
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Patent reform and intellectual property issues, including issues surrounding patent settlements HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding follow-on biologics/pathway for biosimilar pharmaceuticals
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Prescription Drug Importation
Source: Senate LDA
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare/Medicaid dual eligibles HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding patient savings in Medicare Part D coverage gap HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare Part D pharmaceutical pricing
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Prescription Drug Importation
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Patent reform and intellectual property issues, including issues surrounding patent settlements HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding follow-on biologics/pathway for biosimilar pharmaceuticals
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Prescription Drug Importation
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare/Medicaid dual eligibles HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding patient savings in Medicare Part D coverage gap HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare Part D pharmaceutical pricing
Lower PRICED Drugs Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 5122-Defense Authorization Bill-re price control issues. S.2766-Defense Authorization Bill- re price control issues. Prescription Drug User Fee Act issues. S.3695, Food, Drug, & Cosmetic Act amendments, provisions regarding authorized generic drugs and the 180 day exclusivity period; S.2300,Lower Priced Drug Act, provisions relating to 180 day exclusivity regarding period pediatric studies.
Pharmaceutical Market Access and Drug Safety Act of 2005
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Direct to Consumer Advertising issues. S.334-Pharmaceutical Market Access & Drug Safety Act of 2005 - re drug importation. S.3807-Enhancing Drug Safety & Innovation of 2006. H.R.5441-Homeland Security Appropriations Bill-re importation issues.
A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 5122-Defense Authorization Bill-re price control issues. S.2766-Defense Authorization Bill- re price control issues. Prescription Drug User Fee Act issues. S.3695, Food, Drug, & Cosmetic Act amendments, provisions regarding authorized generic drugs and the 180 day exclusivity period; S.2300,Lower Priced Drug Act, provisions relating to 180 day exclusivity regarding period pediatric studies.
Enhancing Drug Safety and Innovation Act of 2006
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Direct to Consumer Advertising issues. S.334-Pharmaceutical Market Access & Drug Safety Act of 2005 - re drug importation. S.3807-Enhancing Drug Safety & Innovation of 2006. H.R.5441-Homeland Security Appropriations Bill-re importation issues.
Patent Reform Act of 2006
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.2795-Patent Reform Act of 2005-re reforms to the patent system. S.3818-Patent Reform Act of 2006-re reforms to the patent system.
Homeland Emergency Responders Organization Act of 2002
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Direct to Consumer Advertising issues. S.334-Pharmaceutical Market Access & Drug Safety Act of 2005 - re drug importation. S.3807-Enhancing Drug Safety & Innovation of 2006. H.R.5441-Homeland Security Appropriations Bill-re importation issues.
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare/Medicaid dual eligibles HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding patient savings in Medicare Part D coverage gap HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Medicare Part D pharmaceutical pricing
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2006 · year_end · YY
H.R. 5337-National Security Foreign Investment Reform Act-re foreign investments in the US.
H.R. 3196-National Institute of Health Reauthorization-re tax breaks for research and development.
Direct to Consumer Advertising issues. S.334-Pharmaceutical Market Access & Drug Safety Act of 2005 - re drug importation. S.3807-Enhancing Drug Safety & Innovation of 2006. H.R.5441-Homeland Security Appropriations Bill-re importation issues.
Medicare Part D outreach efforts & participation in CMS Partnership Strategy Group. Medicaid Reform & Medicare/Patient Assistance Programs integration issues.
H.R. 5122-Defense Authorization Bill-re price control issues. S.2766-Defense Authorization Bill- re price control issues. Prescription Drug User Fee Act issues. S.3695, Food, Drug, & Cosmetic Act amendments, provisions regarding authorized generic drugs and the 180 day exclusivity period; S.2300,Lower Priced Drug Act, provisions relating to 180 day exclusivity regarding period pediatric studies.
H.R.2795-Patent Reform Act of 2005-re reforms to the patent system. S.3818-Patent Reform Act of 2006-re reforms to the patent system.
H.R.6275-Minority Outreach-re health disparities bill.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2004 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE